1.
Understanding the rise of cardiometabolic diseases in low- and middle-income countries
by Miranda, J Jaime
Nature medicine, 2019-11, Vol.25 (11), p.1667-1679
2.
Mitochondrial Disorders in the Nervous System
by DIMAURO, Salvatore
Annual review of neuroscience, 2008, Vol.31 (1), p.91-123
3.
Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers
by Mars, Nina
Nature medicine, 2020-04, Vol.26 (4), p.549-557
4.
NAXE Mutations Disrupt the Cellular NAD(P)HX Repair System and Cause a Lethal Neurometabolic Disorder of Early Childhood
by Kremer, Laura S
American journal of human genetics, 2016-10-06, Vol.99 (4), p.894-902
5.
Role of Endoplasmic Reticulum Stress in Metabolic Disease and Other Disorders
by Ozcan, Lale
Annual review of medicine, 2012-02-18, Vol.63 (1), p.317-328
6.
Metabolically Healthy Obesity and Risk of All-Cause and Cardiovascular Disease Mortality
by Hamer, Mark
The journal of clinical endocrinology and metabolism, 2012-07, Vol.97 (7), p.2482-2488
7.
Trabecular Bone Score (TBS)—A Novel Method to Evaluate Bone Microarchitectural Texture in Patients With Primary Hyperparathyroidism
by Silva, Barbara Campolina
The journal of clinical endocrinology and metabolism, 2013-05, Vol.98 (5), p.1963-1970
8.
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013:...
by Burnett, Richard
The Lancet (British edition), 2015, Vol.386 (10010), p.2287-2323
9.
Epigenetic mechanisms that underpin metabolic and cardiovascular diseases
by Gluckman, Peter D
Nature reviews. Endocrinology, 2009-07, Vol.5 (7), p.401-408
10.
Use of a Mouse In Vitro Fertilization Model to Understand the Developmental Origins of Health and Disease Hypothesis
by Feuer, Sky K
Endocrinology (Philadelphia), 2014-05, Vol.155 (5), p.1956-1969
11.
Time‐restricted feeding and risk of metabolic disease: a review of human and animal studies
by Rothschild, Jeff
Nutrition reviews, 2014-05, Vol.72 (5), p.308-318
12.
The inflammasome NLRs in immunity, inflammation, and associated diseases
by Davis, Beckley K
Annual review of immunology, 2011, Vol.29 (1), p.707-735
13.
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with...
by Bernardino, Jose I
The Lancet (British edition), 2015, Vol.2 (11), p.73
14.
Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease
by Karlsson, Torgny
Nature medicine, 2019-09, Vol.25 (9), p.1390-1395
15.
Childhood Cardiometabolic Outcomes of Maternal Obesity During Pregnancy: The Generation R Study
by Gaillard, Romy
Hypertension (Dallas, Tex. 1979), 2014-04, Vol.63 (4), p.683-691
16.
Metabolic bone disease of prematurity: causes, recognition, prevention, treatment and long-term consequences
by Chinoy, Amish
Archives of disease in childhood. Fetal and neonatal edition, 2019-09, Vol.104 (5), p.F560-F566
17.
Sugar consumption, metabolic disease and obesity: The state of the controversy
by Stanhope, Kimber L
Critical reviews in clinical laboratory sciences, 2016-01-02, Vol.53 (1), p.52-67
18.
Contemporary view of the clinical relevance of magnesium homeostasis
by Ayuk, John
Annals of Clinical Biochemistry, 2014-03, Vol.51 (2), p.179-188
19.
Understanding the Physiology of FGF21
by Fisher, Ffolliott Martin
Annual review of physiology, 2016-02-10, Vol.78 (1), p.223-241
20.
Decreased Circulating Levels of Spexin in Obese Children
by Kumar, Seema
The journal of clinical endocrinology and metabolism, 2016-07, Vol.101 (7), p.2931-2936
